These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19605591)

  • 1. Immune control of mammalian gamma-herpesviruses: lessons from murid herpesvirus-4.
    Stevenson PG; Simas JP; Efstathiou S
    J Gen Virol; 2009 Oct; 90(Pt 10):2317-2330. PubMed ID: 19605591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Control of
    Stevenson PG
    Viral Immunol; 2020 Apr; 33(3):225-232. PubMed ID: 31334688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A battle for survival: immune control and immune evasion in murine gamma-herpesvirus-68 infection.
    Stevenson PG; Boname JM; de Lima B; Efstathiou S
    Microbes Infect; 2002 Sep; 4(11):1177-82. PubMed ID: 12361918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of murine gamma-herpesvirus infection.
    Nash AA; Dutia BM; Stewart JP; Davison AJ
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid infection links epithelial and B cell tropisms of Murid Herpesvirus-4.
    Frederico B; Milho R; May JS; Gillet L; Stevenson PG
    PLoS Pathog; 2012 Sep; 8(9):e1002935. PubMed ID: 23028329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine protection against murid herpesvirus-4 is maintained when the priming virus lacks known latency genes.
    Lawler C; Simas JP; Stevenson PG
    Immunol Cell Biol; 2020 Jan; 98(1):67-78. PubMed ID: 31630452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane association of a model CD4
    Yunis J; Redwood AJ; Belz GT; Stevenson PG
    Immunol Cell Biol; 2020 Apr; 98(4):332-343. PubMed ID: 31997396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murid herpesvirus-4 exploits dendritic cells to infect B cells.
    Gaspar M; May JS; Sukla S; Frederico B; Gill MB; Smith CM; Belz GT; Stevenson PG
    PLoS Pathog; 2011 Nov; 7(11):e1002346. PubMed ID: 22102809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the host response to a gamma-herpesvirus.
    Doherty PC; Christensen JP; Belz GT; Stevenson PG; Sangster MY
    Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):581-93. PubMed ID: 11313013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ T cell evasion mandates CD4+ T cell control of chronic gamma-herpesvirus infection.
    Tan CSE; Lawler C; Stevenson PG
    PLoS Pathog; 2017 Apr; 13(4):e1006311. PubMed ID: 28394921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CD4
    Lawler C; Stevenson PG
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects of a novel vaccination strategy for human gamma-herpesviruses.
    Wu TT; Blackman MA; Sun R
    Immunol Res; 2010 Dec; 48(1-3):122-46. PubMed ID: 20717741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional heterogeneity in the CD4+ T cell response to murine γ-herpesvirus 68.
    Hu Z; Blackman MA; Kaye KM; Usherwood EJ
    J Immunol; 2015 Mar; 194(6):2746-56. PubMed ID: 25662997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single CD8+ T cell epitope sets the long-term latent load of a murid herpesvirus.
    Marques S; Alenquer M; Stevenson PG; Simas JP
    PLoS Pathog; 2008 Oct; 4(10):e1000177. PubMed ID: 18846211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen expression during murine gamma-herpesvirus infection.
    Woodland DL; Flaño E; Usherwood EJ; Liu Luzheng ; Kim IJ; Husain SM; Sample JT; Blackman MA
    Immunobiology; 2001 Dec; 204(5):649-58. PubMed ID: 11846230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with murid herpesvirus-4 glycoprotein B reduces viral lytic replication but does not induce detectable virion neutralization.
    May JS; Stevenson PG
    J Gen Virol; 2010 Oct; 91(Pt 10):2542-52. PubMed ID: 20519454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining immune engagement thresholds for in vivo control of virus-driven lymphoproliferation.
    Godinho-Silva C; Marques S; Fontinha D; Veiga-Fernandes H; Stevenson PG; Simas JP
    PLoS Pathog; 2014 Jun; 10(6):e1004220. PubMed ID: 24967892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine herpesvirus pathogenesis: a model for the analysis of molecular mechanisms of human gamma herpesvirus infections.
    Rajćáni J; Kúdelová M
    Acta Microbiol Immunol Hung; 2005; 52(1):41-71. PubMed ID: 15957234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune evasion by gamma-herpesviruses.
    Stevenson PG
    Curr Opin Immunol; 2004 Aug; 16(4):456-62. PubMed ID: 15245739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68.
    Aricò E; Monque DM; D'Agostino G; Moschella F; Venditti M; Kalinke U; Allen DJ; Stewart JP; Nash AA; Belardelli F; Ferrantini M
    Vaccine; 2011 May; 29(23):3935-44. PubMed ID: 21481326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.